https://clinicaltrials.gov/ct2/show/NCT04483700?type=Intr
https://clinicaltrials.gov/ct2/show/NCT04483700?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=07%2F09%2F2020&lupd_d=14&sort=nwst
STUDY TITLE:
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy
DESCRIPTION:
Condition: Ankylosing Spondylitis
Interventions: Drug: Filgotinib; Drug: Placebo to Match Filgotinib
Sponsors: Gilead Sciences; Galapagos NV
Not yet recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT04483700
FIRST POSTED:
Thu, 23 Jul 2020 12:00:00 EDT
LAST UPDATE POSTED:
07/23/20 07:30AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT04483700?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=07%2F09%2F2020&lupd_d=14&sort=nwst
